redirect to https://www.japantimes.co.jp/news/2022/04/09/business/eisai%2Dalzheimers%2Ddrug%2Dapplication/<script>window.location.href = 'mailto:?subject=japan&#39;s eisai still seeking accelerated u.s. review of alzheimer&#39;s drug&body=https://www.japantimes.co.jp/news/2022/04/09/business/eisai%2Dalzheimers%2Ddrug%2Dapplication/';setTimeout(function(){window.location.href= 'https://www.japantimes.co.jp/news/2022/04/09/business/eisai%2Dalzheimers%2Ddrug%2Dapplication/'},500);</script>